Blood test may catch melanoma recurrence months before scans
NCT ID NCT06246227
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a blood test that detects tumor DNA can find melanoma recurrence earlier than standard methods. Researchers will follow 467 high-risk patients who have had primary melanoma removed. If the test works, it could lead to faster treatment and better outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
circulating tumor DNA (ctDNA) blood test
What this could lead to
If successful, this blood test could help catch melanoma recurrence earlier than current scans or exams, potentially improving treatment timing and outcomes.
What could go wrong
This is an observational study, not a treatment trial. The test may not detect all recurrences, and earlier detection does not guarantee better survival. Results need validation in larger trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Detp. of Pastic and Reconstructive Surgery, Herlev Hospital
Herlev, 2730, Denmark